Cefadroxil + Ambroxol HCl Capsules Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva develops Cefadroxil + Ambroxol HCl Capsules for bacterial respiratory infections associated with mucus accumulation and productive cough conditions. The formulation is commonly administered in bronchial infections, throat infections, chest congestion, and upper respiratory bacterial conditions requiring combined antibacterial and mucolytic therapy.

Cefadroxil works by eliminating infection-causing bacteria, while Ambroxol HCl reduces mucus viscosity and improves airway secretion clearance. As a recognized Respiratory Antibiotic Capsules Supplier, Genliva manufactures combination respiratory care formulations designed for effective infection control and improved breathing comfort.

Known as a Cefadroxil Ambroxol Capsules Exporter, Genliva Wellness LLP supplies respiratory antibacterial formulations to pharmaceutical distributors and international healthcare markets.

Cefadroxil + Ambroxol HCl Capsules are formulated for respiratory infection and mucus control therapies.

Antibiotic and mucolytic capsule combination
Helps reduce respiratory bacterial infections
Improves airway mucus clearance
Stable oral capsule dosage form
Manufactured using quality pharmaceutical ingredients
Designed for respiratory antibacterial care

This formulation is commonly used for respiratory infection treatment and productive cough management.

Treatment of throat and bronchial infections
Management of productive cough conditions
Used in chest congestion therapies
Helps clear mucus from respiratory passages
Controls bacterial respiratory infections effectively

Cefadroxil + Ambroxol HCl Capsules combine antibacterial and mucolytic action for respiratory care.

Reduces bacterial respiratory infections effectively
Improves mucus expulsion and airway clearance
Useful in chest congestion and cough treatment
Helps improve breathing comfort during infections
Provides dual respiratory therapeutic action